We are excited to share that Fusix Biotech is the winner of the 2023 Merck Advance Biotech Grant. Fusix Biotech GmbH Biotech led by Dr. Jennifer Altomonte took home the first price, showcasing groundbreaking work that captivated everyone present. Merck understands the challenges emerging biotech companies face in the quest to push the next generation of drugs to market. This is why they have developed the Advance Biotech Grant programs which occurs on regular basis in different regions of the world. These programs award grant recipients with products, services and consultation support to advance production and help accelerate their path to commercialization.
